A method for diagnosing ovarian cancer, using thioredoxin 1 as a diagnostic marker, comprising:
- (a) adding antibodies specifically binding to thioredoxin 1 to specimen of interest;
- (b) measuring the expression level of thioredoxin 1 in a specimen of interest by measuring the extent of said thioredoxin 1 and anti-thioredoxin 1 antibody complex;
- (c) comparing the measured expression level of thioredoxin 1 in the specimen of interest with that of normal tissue;
- and
- (d) predicting a likelihood of becoming cancerous when the measured expression level is higher than that of normal tissue.